Search results
AbbVie (ABBV) Gets FDA Rejection for Parkinson's Candidate
Zacks via Yahoo Finance· 1 year agoAbbVie ABBV announced that FDA has issued a complete response letter (CRL) to its new drug...
AbbVie (ABBV) to Boost Immunology Pipeline With New Acquisition
Zacks via Yahoo Finance· 2 years agoAbbVie Inc. ABBV recently announced that it has acquired UK-based private biotech, DJS Antibodies...
Can AbbVie (ABBV) Protect Revenues After Humira Patent Loss?
Zacks via Yahoo Finance· 10 months agoAbbVie’s ABBV key blockbuster immunology medicine, Humira lost patent protection in the United...
AbbVie (ABBV) Beats Q4 Earnings Estimates, Misses on Sales
Zacks via Yahoo Finance· 1 year agoAbbVie Inc. ABBV reported adjusted earnings of $3.60 per share for the fourth quarter of 2022,...
Will AbbVie's (ABBV) New Drugs Continue to Drive Q4 Earnings?
Zacks via Yahoo Finance· 1 year agoAbbVie’s ABBV fourth-quarter revenues are likely to be driven by revenues generated from the sales...
AbbVie (ABBV) to Acquire ImmunoGen (IMGN) for $10.1 Billion
Zacks via Yahoo Finance· 6 months agoAbbVie (ABBV) offers to buy ImmunoGen (IMGN) for approximately $10.1 billion, which will diversify...
AbbVie (ABBV) to Report Q2 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 years agoAbbVie's (ABBV) second-quarter results are expected to reflect the impact of strong demand for...
AbbVie (ABBV), J&J to Withdraw 2 Blood Cancer Nods for Imbruvica
Zacks via Yahoo Finance· 1 year agoAbbVie (ABBV)/J&J's (JNJ) decision to withdraw the FDA's accelerated approval for Imbruvica in two...
AbbVie (ABBV) Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU
Zacks via Yahoo Finance· 6 days agoAbbVie (ABBV) announces that the EMA's CHMP issued a positive opinion on its regulatory filing...
AbbVie (ABBV), J&J's Imbruvica Gets FDA Nod for cGVHD in Kids
Zacks via Yahoo Finance· 2 years agoAbbVie (ABBV) and J&J's (JNJ) Imbruvica gets FDA nod for label expansion to treat pediatric patients...